1.5380
0.0000
(0.00%)
As of April 8 at 3:29:02 PM GMT+2. Market Open.
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Didier Laurens | CEO, MD, General Director & Director | 267.99k | -- | 1967 |
| Mr. Laurent Cassedanne | Deputy CEO, Deputy GM & Head Pharmacist and Director | 175.3k | -- | 1968 |
| Isabelle Kervella | Chief Financial Officer | -- | -- | -- |
| Dr. André Ulmann M.D., Ph.D. | Chief Medical Officer & Non-Voting Director | -- | -- | 1950 |
| Ms. Hege Hellstrom | Chief Commercial Officer | -- | -- | 1965 |
| Mr. Robbie McCarthy | General Manager of Advicenne Inc. | -- | -- | -- |
Advicenne S.A.
3ème étage
262 Rue du Faubourg Saint-Honore
Paris, 75008
France
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 21
Description
Advicenne S.A., a specialty pharmaceutical company, develops, commercializes, and markets treatments for rare renal diseases in France and internationally. The company offers Sibnayal for the treatment of metabolic disorders, distal renal tubular acidosis, and cystinuria. It also distributes Likozam, a formulation of clobazam for the treatment of short-term symptomatic of severe, disabling, or condition-causing anxiety unacceptable distress; and Levidcen, a galenic form of levetiracetam for the treatment of epileptic seizures. Advicenne S.A. was incorporated in 2007 and is headquartered in Paris, France.
Corporate Governance
Advicenne S.A.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 27, 2025 at 10:59 AM UTC
Advicenne S.A. Earnings Date
Recent Events
Recent Events Information Not Available